Arresting frailty and sarcopenia in cirrhosis: Future prospects
Hui‐Wei Chen, Michael A. Dunn – 28 February 2018
The Role of Intestinal C‐type Regenerating Islet Derived‐3 Lectins for Nonalcoholic Steatohepatitis
Sena Bluemel, Lirui Wang, Cameron Martino, Suhan Lee, Yanhan Wang, Brandon Williams, Angela Horvath, Vanessa Stadlbauer, Karsten Zengler, Bernd Schnabl – 28 February 2018 – C‐type regenerating islet derived‐3 (Reg3) lectins defend against pathogens and keep commensal bacteria at a distance. Deficiency of Reg3g and Reg3b facilitates alcohol‐induced bacterial translocation and alcoholic liver disease. Intestinal Reg3g is down‐regulated in animal models of diet‐induced obesity, but the functional consequences for nonalcoholic steatohepatitis (NASH) are unknown.
Pro: Moderate alcohol use is beneficial in nonalcoholic steatohepatitis
Scott McHenry, Saad Alghamdi, Mauricio Lisker‐Melman – 28 February 2018
Health literacy and liver disease
Rishabh Gulati, Mohammad Nawaz, Nikolaos T. Pyrsopoulos – 28 February 2018
Problematic lesions in cirrhosis
Alessandro Furlan, Amir A. Borhani – 28 February 2018
Problematic lesions in cirrhosis
Alessandro Furlan, Amir A. Borhani – 28 February 2018
Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use
Maham Lodhi, Jaimin Amin, Sheila Eswaran – 28 February 2018
Use of the CRISPR/Cas9‐based epigenetic gene activation system In Vivo: A new potential therapeutic modality
Samar H. Ibrahim, Keith D. Robertson – 28 February 2018
Pro: Moderate alcohol use is beneficial in nonalcoholic steatohepatitis
Scott McHenry, Saad Alghamdi, Mauricio Lisker‐Melman – 28 February 2018
Think global, act local: Responsibility for the liver transplant candidate
Peter L. Abt, Kim M. Olthoff – 28 February 2018